However, no significant difference in mortality found between remdesivir and placebo groups
No infection identified among surgeons following procedure; postoperative complications rarely seen
Combined MICT, HIIT intervention group had no difference in mortality versus recommended guidelines
Most older adults taking multiple medications have never had a comprehensive medication review
No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir
No clinical benefit seen versus placebo for hospital-based health care workers exposed to patients with COVID-19
If enough people in the U.S. pass on vaccine, the nation may not be able to achieve herd immunity
MIS-A related to SARS-CoV-2 infection resembles MIS in children; respiratory symptoms often minimal
Agency says it is especially true in enclosed spaces with inadequate ventilation
Higher case fatality rates found to be independent of demographic factors, such as age, sex, and race